Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
A session featuring roundtable discussions from the 18th Meeting of the International Society of Amyloidosis (ISA) which was held in Heidelberg, Germany, on 4-8 September 2022.
Welcome to The Amyloidosis Sessions brought to you by the Video Journal of Hematological Oncology (VJHemOnc). This exclusive session features roundtable discussions from the 18th Meeting of the International Society of Amyloidosis (ISA) with leading experts Shaji Kumar, MD, Mayo Clinic, Rochester, MN, Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM, University College London, London, UK, Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, and Morie Gertz, MD, MACP, Mayo Clinic, Rochester, MN, who share their highlights in light chain (AL) and transthyretin (ATTR) amyloidosis from the meeting.
The experts focus on a variety of topics including the evolution of diagnostic approaches and improvements in imaging techniques to diagnose AL and ATTR amyloidosis early, the mechanisms driving the progression of AL amyloidosis to multiple myeloma, unmet needs in currently used risk stratification systems for AL amyloidosis, the role of hematopoietic stem cell transplantation (HSCT) in the era of daratumumab-based therapies, the emerging importance of measurable residual disease (MRD) assessment to predict organ response, and the potential impact of anti-fibril strategies in AL amyloidosis.
The Amyloidosis Channel on VJHemOnc receives independent medical education support from:
